Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Cepheid, a large biotechnology company ... or another Bay Area tech company? Contact tech reporter Stephen Council securely at [email protected] or on Signal at 628-204-5452.

Both companies ... while Signal has several drugs in the pipeline but none producing revenue. “It's a good match for Celgene,” says Caroline Copithorne, biotechnology analyst at Morgan Stanley ...